Global Alliance for Tb Drug Development (Tb Alliance)
Tuberculosis non-profit drug development company
Based in NY
AI Overview
With $700K in lobbying spend across 33 quarterly filings, Global Alliance for Tb Drug Development (Tb Alliance) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $80K |
| 2019 | $120K |
| 2020 | $100K |
| 2021 | $80K |
| 2022 | $80K |
| 2023 | $80K |
| 2024 | $80K |
| 2025 | $80K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Global Alliance for Tb Drug Development (Tb Alliance) disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Foreign Relations, Budget/Appropriations
Annual appropriations for Labor, Health & Human Services, Department of Defense, and State and Foreign Operations bills
Report language and funding for TB programs at USAID, HHS and DoD
US role in TB research and development
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.